Search Results 71-80 of 1617 for 用ai写论文的网站,工业互联网ai公司,ai绘画网站模型,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. A Multicenter Pragmatic Implementation Study of AI-ECG-Based Clinical Decision Support Software to Identify Low LVEF

    About this study. The purpose of this stuyd is to evaluate the impact of an ECG-based artificial intelligence (AI-ECG) algorithm to detect low left ...

  2. https://www.mayoclinic.org/~/media/0439A7376021433E8FB3180F95C8FF95

  3. Publications - Xuan Ding, M.D., Ph.D. - Mayo Clinic

    ... AI, Morrow DA, Daniels LB. In-Hospital Mortality Risk Among Transfers to Cardiac Intensive Care Units. JACC Adv. 2025 Jul 31; 102046 Epub 2025 July 31. View ...

  4. Diego Zaquera Carvalho, M.D., M.S. - Mayo Clinic Faculty Profiles

    His goal is to develop novel therapeutic approaches to slow down neurodegeneration through sleep-based interventions. Focus areas. AI; Chronic insomnia ...

  5. Publications - Jing Qian, Ph.D. - Mayo Clinic

    Fetea, R. B. Cakirli, R. F. Casten, D. D. Warner, E. A. McCutchan, D. A. Meyer, A. Heinz, H. Ai, G. Gürdal, J. Qian, ...

  6. Hu Li, Ph.D. - Mayo Clinic Faculty Profiles

    Hu Li, Ph.D., improves patient care by developing state-of-the-art systems biology concepts, machine learning and artificial intelligence (AI) approaches to ...

  7. Publications - Christoph Wald, M.D., Ph.D. - Mayo Clinic

    Multi-Institutional Evaluation and Training of Breast Density Classification AI Algorithm Using ACR Connect and AI-LAB. J Am Coll Radiol. 2024 Nov 17 [Epub ...

  8. Use of artificial intelligence tools and electronic health record data for pancreatic cancer risk prediction - Mayo Clinic

    This presents an opportunity to leverage advances in AI and ML capabilities to develop EHR-based applications that accurately identify both known and novel risk ...

  9. Lifeng Yu, Ph.D. - Mayo Clinic Faculty Profiles

    ... This includes radiation dose optimization, image quality assessment, multi-energy and photon-counting-detector CT, and AI applications in CT image formation.

  10. Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has Progressed on or After CDK 4/6 Treatment With an Aromatase Inhibitor (AI) or Fulvestrant - Mayo Clinic

    Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has ...